查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498761

基於 PCR 的傳染病市場，按疾病類型、應用、最終用戶、技術、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

PCR-based Infectious Diseases Market, By Disease Type, By Application, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年基於PCR的傳染病市場規模為47.9032億美元，2024年至2032年複合年成長率為6.91%。

基於PCR的傳染病市場-市場動態

採用基於 PCR 的 POCT 設備的趨勢日益明顯

基於 PCR 的 POCT 設備通常在幾分鐘內即可提供快速、準確的結果，從而實現快速診斷和及時干預。這在需要立即就患者護理做出決定的環境中尤其重要。許多基於 PCR 的 POCT 設備與數位健康技術整合，例如智慧型手機應用程式或基於雲端的平台，從而實現即時資料分析、遠端監控以及醫療保健提供者和患者之間的無縫通訊。據世界衛生組織（WHO）稱，人類免疫缺陷病毒（HIV）是慢性傳染病愛滋病的根源。世界衛生組織 (WHO) 對 2021 年的估計顯示，全球有 65 萬人死於愛滋病毒相關原因，全球仍有 3,840 萬人攜帶該病毒。

基於 PCR 的傳染病市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.91% 左右的複合年成長率成長

根據疾病類型細分，預計病毒性疾病將在 2023 年呈現最大市場佔有率

從應用細分來看，臨床診斷是2023年的主導類型

根據最終用戶細分，醫院和診所是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

基於 PCR 的傳染病市場區隔分析：

全球基於 PCR 的傳染病市場根據疾病類型、應用、最終用戶、技術和地區進行細分。

根據最終用戶，市場分為四類：醫院和診所、診斷實驗室、研究機構以及製藥和生物技術公司。醫院是最大的最終使用者群體。進行PCR分子診斷等各種診斷測試的主要醫療機構是醫院。在醫院中，PCR 技術對於準確、迅速地識別多種疾病至關重要。需要快速、準確的診斷測試來為治療和患者管理選擇提供資訊，這推動了醫院對 PCR 分子診斷的需求。

市場根據應用分為兩類：臨床診斷、研究應用和流行病學研究。臨床診斷是最大的部分。基於 PCR 的傳染病檢測對於檢測和追蹤各種病原體（例如細菌、病毒和真菌）至關重要。世界各地傳染病的流行推動了基於 PCR 的傳染病檢測的需求，這些傳染病包括呼吸道感染、性傳染病以及與醫療保健相關的感染。

基於 PCR 的傳染病市場 - 地理洞察

由於完善的醫療基礎設施、高額醫療支出以及較早採用 PCR 等先進診斷技術，北美地區往往擁有重要的市場佔有率。美國和加拿大是這個市場的主要貢獻者。不同州和省的監管框架和醫療保健政策可能有所不同，從而影響市場動態。例如，報銷政策或監管批准的差異可能會影響基於 PCR 的診斷的採用和滲透。由於先進的醫療保健系統和傳染病的高發病率，歐洲國家也擁有相當大的市場佔有率。德國、英國、法國和義大利等國家是基於 PCR 的傳染病診斷的主要市場。

基於PCR的傳染病市場-競爭格局：

該市場的特點是存在多個關鍵參與者，包括生物技術和診斷公司、學術研究機構和醫療保健組織。基於 PCR 的傳染病領域的主要參與者包括 Abbott Laboratories、Takara Bio, Inc、Thermo Fisher Scientific、Qiagen NV、Roche Diagnostics 等。羅氏是基於 PCR 的診斷市場的主要參與者，為傳染病提供廣泛的基於 PCR 的檢測，包括愛滋病毒、肝炎和呼吸道感染。 Thermo Fisher 提供廣泛的基於 PCR 的產品和解決方案組合，用於傳染病檢測，包括 COVID-19、呼吸道感染和性傳播感染的檢測。 Qiagen 提供一系列用於傳染病檢測的基於 PCR 的檢測和樣本製備技術，包括呼吸道感染、胃腸道感染和性傳播感染的檢測。

最近的發展：

2022 年 9 月，西北大學的子公司 Minute Molecular Diagnostics 創建了一種針對 COVID-19 的快速聚合酶鏈反應 (PCR) 測試。研究人員正在使用 Minute Molecular 的 DASH 分析儀（一種小型攜帶式設備）來創建快速 PCR 測試，該設備可在大約 15 分鐘內提供易於讀取的結果。

2021 年 8 月，QIAGEN 和 GT Molecular 合作提出了基於 QIAcuity 數位 PCR 創新的完整 SARS-CoV-2 廢水辨識解決方案。

目錄

第 1 章：基於 PCR 的傳染病市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 基於 PCR 的傳染病市場片段（依疾病類型）
    • 基於 PCR 的傳染病市場片段（依應用）
    • 最終用戶基於 PCR 的傳染病市場片段
    • 基於 PCR 的傳染病市場片段（按技術）
    • 基於 PCR 的傳染病市場片段（按國家/地區）
    • 按地區分類的基於 PCR 的傳染病市場片段
  • 競爭洞察

第 3 章：基於 PCR 的傳染病主要市場趨勢

  • 基於 PCR 的傳染病市場促進因素
    • 市場促進因素的影響分析
  • 基於 PCR 的傳染病市場限制
    • 市場限制影響分析
  • 基於 PCR 的傳染病市場機會
  • 基於PCR的傳染病市場未來趨勢

第 4 章：基於 PCR 的傳染病產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基於 PCR 的傳染病市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基於 PCR 的傳染病市場格局

  • 基於 PCR 的傳染病市佔率分析，2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基於 PCR 的傳染病市場 - 按疾病類型

  • 概述
    • 按疾病類型分類的細分市場佔有率分析
    • 病毒性疾病
      • 愛滋病
      • 肝炎
      • 流感
    • 細菌性疾病
      • 結核
      • 抗甲氧西林金黃色葡萄球菌
    • 黴菌感染
      • 念珠菌病
    • 寄生蟲感染
    • 其他

第 8 章：基於 PCR 的傳染病市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 臨床診斷
    • 研究應用
    • 流行病學研究

第 9 章：基於 PCR 的傳染病市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 診斷實驗室
    • 研究機構
    • 製藥與生物技術公司

第 10 章：基於 PCR 的傳染病市場 - 按技術分類

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 傳統PCR
    • 即時螢光定量PCR (qPCR)
    • 數位 PCR (dPCR)
    • 逆轉錄酶 PCR (RT-PCR)
    • 巢式PCR
    • 多重PCR

第 11 章：基於 PCR 的傳染病市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美基於 PCR 的傳染病主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按疾病類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 北美市場規模和預測（按技術）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基於 PCR 的傳染病主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按疾病類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 歐洲市場規模與預測（按技術）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基於 PCR 的傳染病主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按疾病類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 亞太地區市場規模與預測（按技術）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基於 PCR 的傳染病主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疾病類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 拉丁美洲市場規模與預測（按技術）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲基於 PCR 的傳染病主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疾病類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 中東和非洲市場規模及預測（按技術）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 基於 PCR 的傳染病產業

  • 競爭儀表板
  • 公司簡介
    • Abbott Laboratories
    • Takara Bio, Inc
    • Thermo Fisher Scientific
    • Qiagen NV
    • Bio-Rad Laboratories, Inc
    • Roche Diagnostics
    • Cepheid
    • DiaSorin
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2930

REPORT HIGHLIGHT

PCR-based Infectious Diseases Market size was valued at USD 4,790.32 million in 2023, expanding at a CAGR of 6.91% from 2024 to 2032.

The PCR-based infectious diseases market refers to the segment of the healthcare industry focused on diagnostic techniques that utilize Polymerase Chain Reaction (PCR) technology to identify pathogens responsible for infectious diseases. PCR is a molecular biology technique used to amplify DNA segments, making it a powerful tool for detecting the presence of viruses, bacteria, fungi, and other pathogens in clinical samples. The market has been experiencing steady growth due to several factors, including the increasing incidence of infectious diseases, advancements in PCR technology, growing demand for rapid and accurate diagnostic techniques, and rising healthcare expenditure. There is a growing trend towards the adoption of PCR-based POCT devices, which enable rapid and decentralized testing, particularly in resource-limited settings and for outbreak management.

PCR-based Infectious Diseases Market- Market Dynamics

Increasing Trend Toward the Adoption of PCR-based POCT Devices

PCR-based POCT devices offer rapid and accurate results, often within minutes, allowing for quick diagnosis and timely intervention. This is especially crucial in settings where immediate decisions need to be made regarding patient care. Many PCR-based POCT devices are integrated with digital health technologies, such as smartphone apps or cloud-based platforms, enabling real-time data analysis, remote monitoring, and seamless communication between healthcare providers and patients. According to the World Health Organization (WHO), the human immunodeficiency virus (HIV) is the source of the chronic infectious illness AIDS. World Health Organization (WHO) estimates for 2021 show that 0.65 million individuals died from HIV-related causes and that 38.4 million people worldwide were still living with the virus.

PCR-based Infectious Diseases Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.91% over the forecast period (2024-2032)

Based on disease type segmentation, viral diseases were predicted to show maximum market share in the year 2023

Based on application segmentation, Clinical diagnostics was the leading type in 2023

Based on end-user segmentation, Hospitals & Clinics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

PCR-based Infectious Diseases Market- Segmentation Analysis:

The Global PCR-based Infectious Diseases Market is segmented on the basis of Disease Type, Application, End User, Technology, and Region.

The market is divided into four categories based on end-users: Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, and Pharmaceutical & Biotechnology Companies. Hospitals make up the biggest end-user segment. The main healthcare facilities that conduct a variety of diagnostic tests, such as PCR molecular diagnostics, are hospitals. In hospitals, PCR technology is essential for the precise and prompt identification of a wide range of illnesses. The requirement for quick and accurate diagnostic tests to inform therapy and patient management choices is what drives the demand for PCR molecular diagnostics in hospitals.

The market is divided into two categories based on application: Clinical diagnostics, Research applications, and Epidemiological studies. Clinical diagnostics is the largest segment. PCR-based infectious disease testing is essential for detecting and tracking a wide range of pathogens, such as bacteria, viruses, and fungi. The need for PCR-based infectious disease testing is driven by the prevalence of infectious diseases, including respiratory infections, STDs, and infections linked to healthcare, around the world.

PCR-based Infectious Diseases Market- Geographical Insights

North America region tends to have a significant market share due to well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced diagnostic technologies like PCR. The United States and Canada are key contributors to this market. Regulatory frameworks and healthcare policies can vary between different states and provinces, influencing market dynamics. For example, differences in reimbursement policies or regulatory approvals can impact the adoption and penetration of PCR-based diagnostics. Countries in Europe also have a considerable market share owing to advanced healthcare systems and a high prevalence of infectious diseases. Countries like Germany, the UK, France, and Italy are major markets for PCR-based infectious disease diagnostics.

PCR-based Infectious Diseases Market- Competitive Landscape:

The market is characterized by the presence of several key players, including biotechnology and diagnostic companies, academic research institutions, and healthcare organizations. Major players in PCR-based Infectious Diseases include Abbott Laboratories, Takara Bio, Inc, Thermo Fisher Scientific, Qiagen N.V., Roche Diagnostics etc. These players compete through product innovation, strategic collaborations, and geographical expansion. Roche is a major player in the PCR-based diagnostics market, offering a wide range of PCR-based tests for infectious diseases, including HIV, hepatitis, and respiratory infections. Thermo Fisher provides a broad portfolio of PCR-based products and solutions for infectious disease testing, including assays for COVID-19, respiratory infections, and sexually transmitted infections. Qiagen offers a range of PCR-based assays and sample preparation technologies for infectious disease testing, including tests for respiratory infections, gastrointestinal infections, and sexually transmitted infections.

Recent Developments:

In September 2022, Minute Molecular Diagnostics, a Northwestern University spinoff created a quick polymerase chain reaction (PCR) test for COVID-19. The researchers are employing Minute Molecular's DASH Analyzer, a small, portable device that offers easy-to-read results in around 15 minutes, to create a quick PCR test.

In August 2021, QIAGEN and GT Molecular collaborated to proposal a complete SARS-CoV-2 wastewater recognition resolution based on QIAcuity Digital PCR innovation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories

Takara Bio, Inc

Thermo Fisher Scientific

Qiagen N.V.

Bio-Rad Laboratories, Inc

Roche Diagnostics

Cepheid

DiaSorin

Others

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Viral diseases
  • HIV
  • hepatitis
  • influenza
  • Bacterial diseases
  • tuberculosis
  • MRSA
  • Fungal infections
  • candidiasis
  • Parasitic infections
  • Others

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical diagnostics
  • Research applications
  • Epidemiological studies

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Traditional PCR
  • Real-time PCR (qPCR)
  • Digital PCR (dPCR)
  • Reverse Transcriptase PCR (RT-PCR)
  • Nested PCR
  • Multiplex PCR

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PCR-based Infectious Diseases Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PCR-based Infectious Diseases Market Snippet by Disease Type
    • 2.1.2. PCR-based Infectious Diseases Market Snippet by Application
    • 2.1.3. PCR-based Infectious Diseases Market Snippet by End User
    • 2.1.4. PCR-based Infectious Diseases Market Snippet by Technology
    • 2.1.5. PCR-based Infectious Diseases Market Snippet by Country
    • 2.1.6. PCR-based Infectious Diseases Market Snippet by Region
  • 2.2. Competitive Insights

3. PCR-based Infectious Diseases Key Market Trends

  • 3.1. PCR-based Infectious Diseases Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PCR-based Infectious Diseases Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PCR-based Infectious Diseases Market Opportunities
  • 3.4. PCR-based Infectious Diseases Market Future Trends

4. PCR-based Infectious Diseases Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PCR-based Infectious Diseases Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PCR-based Infectious Diseases Market Landscape

  • 6.1. PCR-based Infectious Diseases Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PCR-based Infectious Diseases Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 7.1.2. Viral diseases
      • 7.1.2.1. HIV
      • 7.1.2.2. hepatitis
      • 7.1.2.3. influenza
    • 7.1.3. Bacterial diseases
      • 7.1.3.1. tuberculosis
      • 7.1.3.2. MRSA
    • 7.1.4. Fungal infections
      • 7.1.4.1. candidiasis
    • 7.1.5. Parasitic infections
    • 7.1.6. Others

8. PCR-based Infectious Diseases Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Clinical diagnostics
    • 8.1.3. Research applications
    • 8.1.4. Epidemiological studies

9. PCR-based Infectious Diseases Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Pharmaceutical & Biotechnology Companies

10. PCR-based Infectious Diseases Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Traditional PCR
    • 10.1.3. Real-time PCR (qPCR)
    • 10.1.4. Digital PCR (dPCR)
    • 10.1.5. Reverse Transcriptase PCR (RT-PCR)
    • 10.1.6. Nested PCR
    • 10.1.7. Multiplex PCR

11. PCR-based Infectious Diseases Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. PCR-based Infectious Diseases Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. PCR-based Infectious Diseases Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. PCR-based Infectious Diseases Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. PCR-based Infectious Diseases Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. PCR-based Infectious Diseases Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- PCR-based Infectious Diseases Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Takara Bio, Inc
    • 12.2.3. Thermo Fisher Scientific
    • 12.2.4. Qiagen N.V.
    • 12.2.5. Bio-Rad Laboratories, Inc
    • 12.2.6. Roche Diagnostics
    • 12.2.7. Cepheid
    • 12.2.8. DiaSorin
    • 12.2.9. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PCR-based Infectious Diseases Market: Disease Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global PCR-based Infectious Diseases Market, by Disease Type 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PCR-based Infectious Diseases Market, by Application 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global PCR-based Infectious Diseases Market, by End User 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global PCR-based Infectious Diseases Market, by Technology 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PCR-based Infectious Diseases Market, by Region 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)